Rigel Pharmaceuticals Inc
F:RI2A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rigel Pharmaceuticals Inc
F:RI2A
|
US |
Intrinsic Value
The intrinsic value for
Rigel Pharmaceuticals Inc (RI2A) under the Base Case is 17.74 EUR.
Compared with the current market price of 10.8 EUR, the stock appears
Undervalued by 39% .
Both DCF and multiples point to undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Rigel Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Rigel Pharmaceuticals Inc
Earnings Waterfall
Rigel Pharmaceuticals Inc
The intrinsic value for
Rigel Pharmaceuticals Inc (RI2A) under the Base Case is 17.74 EUR.
Compared with the current market price of 10.8 EUR, the stock appears Undervalued by 39% .